Lovastatin decreases prolactin and growth hormone gene expression in GH4C1 cells through a cAMP dependent mechanism

Molecular and Cellular Endocrinology

Volumn 130, Issue 1-2, 1997, Pages 93-100

  Lasa, Marina ^a   Chiloeches, Antonio ^a   García, Natalia ^a   Montes, Agustín ^a   Toro, María J ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

G protein; Gene expression; Hormone release; Lovastatin

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLIC AMP; FORSKOLIN; GROWTH HORMONE; GUANINE NUCLEOTIDE BINDING PROTEIN; MEVALONIC ACID; MEVINOLIN; PROLACTIN; TRANSCRIPTION FACTOR PIT 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENE REPRESSION; GROWTH HORMONE RELEASE; HYPOPHYSIS CELL; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROMOTER REGION; RAT; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYCLIC AMP; FORSKOLIN; GENE EXPRESSION; GENES, REPORTER; GROWTH HORMONE; GTP-BINDING PROTEINS; KINETICS; LOVASTATIN; MEVALONIC ACID; PITUITARY GLAND; PROLACTIN; PROMOTER REGIONS (GENETICS); RATS; SIGNAL TRANSDUCTION;

EID: 0030745111     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(97)00077-4     Document Type: Article

References (27)

1. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72, 248-254.
2. Brindle, P.K., Montminy, M.R., 1992. The CREB family of transcription activators. Curr. Opin. Genet. Dev. 2, 199-204.
3. 3 cells. Endocrinology 116, 202-206.
4. 1 cells. FEBS Lett. 361, 46-50.
5. Day, R.N., Maurer, R.A., 1989. The distal enhancer region of the rat prolactin gene contains elements conferring response to multiple hormones. Mol. Endocrinol. 3, 3-9.
6. Day, R.N., Walder, J.A., Maurer, R.A., 1989. A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription. J. Biol. Chem. 264, 431-436.
7. De Wet, J.R., Wood, K.V., DeLuca, M., Helinski, D.R., Subramani, S., 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7, 725-737.
8. Fischberg, D.J., Chen, X., Bancroft, C., 1994. A pit-1 phosphorylation mutant can mediate both basal and induced prolactin and growth hormone promoter activity. Mol. Endocrinol. 8, 1566-1573.
9. Flug, F., Copp, R.P., Casanova, J., Horowitz, Z.D., Janocko, L., Plotnick, M., Samuels, H.H., 1987. Cis-acting elements of the rat growth hormone gene which mediate basal and regulated expression by thyroid hormone. J. Biol. Chem. 262, 6373-6382.
10. sα mutants associated with human pituitary tumors: stimulation of adenosine 3′, 5′-monophosphate response element-binding protein-mediated transcription and of prolactin and growth hormone promoter activity via protein kinase A. Endocrinology 136, 4331-4338.
11. Gibbs, J.B., 1991. Ras C-terminal processing enzymes-new drug targets?. Cell 65, 1-4.
12. Gilman, A., 1990. Regulation of adenylyl cyclase by G proteins. Adv. Sec. Mess. Phosph. Res. 24, 51-57.
13. Gilman, A.G., 1987. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56, 615-649.
14. Goldstein, J.L., Brown, M.S., 1990. Regulation of the mevalonate pathway. Nature (London) 343, 425-430.
15. Gutierrez-Hartmann, A., 1994. Pit-1/GHF-1: A pituitary-specific transcription factor linking general signaling pathways to cell-specific gene expression. Mol. Endocrinol. 8, 1447-1449.
16. Hepler, J.R., Gilman, A.G., 1992. G proteins. Trends Biochem. Sci 17, 383-387.
17. Iñiguez-Lluhi, J.A., Simon, M.I., Robinshaw, J.D., Gilman, A.G., 1992. G protein, βγ-subunits synthesized in Sf9 cells. J. Biol. Chem. 267, 23409-23417.
18. Jakobisiak, M., Bruno, S., Skierski, J.S., Darzynkiewicz, Z., 1991. Cell cycle-specific effects of lovastatin. Proc. Natl. Acad. Sci. USA 88, 3628-3632.
19. Kapiloff, M.S., Mathis, J.M., Nelson, C.A., Lin, C.R., Rosenfeld, M.G., 1991. Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 253, 786-789.
20. Kita, T., Brown, M.S., Goldstein, J.L., 1980. Feedback regulation of 3 hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevilonin, a competitive inhibitor of the reductase. J. Clin. Invest. 66, 1094-1100.
21. Levis, M.J., Bourne, H.R., 1992. Activation of the α-subunit of Gs in intact cells alters its abundance, rate of degradation, and membrane avidity. J. Cell Biol. 119, 1297-1307.
22. Lew, A.M., Hong, Y., Elsholtz, H.P., 1994. Giα2- and Goα-mediated signaling in the Pit-1-dependent inhibition of the prolactin gene promoter. J. Biol. Chem. 269, 12007-12013.
23. Maurer, R.A., 1981. Transcriptional regulation of the prolactin gene by ergocriptine and cyclic AMP. Nature 294, 94-97.
24. McCormick, A., Brady, H., Theill, L.E., Karin, M., 1990. Regulation of the pituitary-specific homeobox gene GHF1 by cell-autonomous and environmental cues. Nature 345, 829-832.
25. Okimura, Y., Howard, P.W., Maurer, R.A., 1994. Pit-1 binding sites mediate transcriptional response to cyclic adenosine 3′, 5′-monophosphate through a mechanism that does not require inducible phosphorylation of Pit-1. Mol. Endocrinol. 8, 1559-1565.
26. Repko, E.M., Maltese, W.A., 1989. Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability. J. Biol. Chem. 264, 9945-9952.
27. Rothblat, G.H., Bamberger, M., Phillips, M.C., 1986. Reverse cholesterol transport. Methods Enzymol. 129, 628-644.